1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Qiagen N.V.
  6. Company
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
Delayed Nyse  -  05/20 04:00:02 pm EDT
45.27 USD   +1.84%
05/19QIAGEN's Eco-Friendlier Products Earn Prestigious ACT Label
BU
05/16QIAGEN NV : Berenberg keeps its Buy rating
MD
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Qiagen N.V.
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid).

In 2019, the group developed more than 500 consumable products and automated solutions through its 35 production sites worldwide.

Net sales break down geographically as follows: the United States (43.5%), America (3.8%), Europe/Middle East/Africa (31.9%) and other (20.8%).

Number of employees : 6 028 people.
Sales per Business
20202021Delta
Consumables and Related1 615.4086.4%1 986.3088.2% +22.96%
Instrumentation254.9013.6%265.3011.8% +4.08%
USD in Million
Sales per region
20202021Delta
United States728.5839%909.6940.4% +24.86%
Europe, Middle East and Africa664.4935.5%786.1234.9% +18.3%
Asia Pacific, Japan and Rest of World362.6019.4%429.8619.1% +18.55%
Other Americas96.885.2%97.694.3% +0.83%
Netherlands17.801%28.301.3% +58.99%
USD in Million
Managers
Name Title Age Since
Thierry Bernard Chief Executive Officer & Managing Director 57 2019
Roland Sackers Vice President-Finance 52 1999
Barthold Piening Senior Vice President & Head-Global Operations 63 2018
Lezette Young Manager-Compliance & Legal - -
John Gilardi Vice President & Head-Investor Relations - 2010
Thomas Neidert Vice President-Global Treasury - 2008
Thomas Schweins, Dr. Senior Vice President-Life Science Business Area 54 2017
Jonathan G. Sheldon, Dr. Senior VP-Digital Insights Business Area 49 2018
Jean-Pascal Viola Head-Corporate Business Development - -
Stephany Foster Head-Global Internal Audit - 2005
Members of the board
Name Title Age Since
Lawrence Rosen Chairman-Supervisory Board 63 2020
Metin Colpan, Dr. Independent Member-Supervisory Board 67 2004
Elizabeth E. Tallett Member-Supervisory Board 71 2011
Elaine R. Mardis, Dr. Independent Member-Supervisory Board 58 2014
Ross L. Levine, Dr. Independent Member-Supervisory Board 49 2016
Toralf Haag, Dr. Member-Supervisory Board 55 2021
Thomas Ebeling Member-Supervisory Board 63 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 230,829,000 226,728,284 98.2% 3,377,000 1.5% 98.2%
Shareholders
NameEquities%
Massachusetts Financial Services Co. 20,508,125 9.03%
PRIMECAP Management Co. 13,133,386 5.78%
Baillie Gifford & Co. 7,169,829 3.16%
Schroder Investment Management Ltd. 6,646,178 2.93%
PSquared Asset Management AG 6,204,979 2.73%
The Vanguard Group, Inc. 5,904,948 2.60%
MFS International (UK) Ltd. 5,836,761 2.57%
Capital Research & Management Co. (World Investors) 5,636,648 2.48%
Norges Bank Investment Management 5,374,504 2.37%
Wellington Management Co. LLP 4,855,279 2.14%
Markets and indexes
- Prime Standard
- DAX 40 / PEA, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  QIA:GR
- Reuters Code :  QIA.DE
- Datastream Code :  
Company contact information
Qiagen N.V.
Hulsterweg 82
NL-5912 PL Venlo

Phone : +31 77 355 6600
Fax : +31 77 355 6658
web site : http://www.qiagen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Qiagen N.V.